Barclays raised the firm’s price target on Levi Strauss (LEVI) to $24 from $20 and keeps an Overweight rating on the shares. The firm says the company’s fiscal Q2 provided further evidence that the business is on the right trajectory with broad-based growth across geographies.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEVI:
- Levi Strauss Reports Strong Earnings with Growth Across Key Segments
- Levi Strauss & Co: Strong Market Position and Growth Potential Justify Buy Rating
- Levi Strauss price target raised to $24 from $21 at Telsey Advisory
- Morning Movers: Capricor Therapeutics plunges following CRL from FDA
- Video: Capricor plunges after CRL, Performance Foods up after seeing interest